Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 3, 2006, Pages 220-225

  Hansen, Axel Kornerup ^a   Ling, Fengjun ^a   Kaas, Anne ^b   Funda, David P ^b,c   Farlov, Helene ^a   Buschard, Karsten ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Kommunehospitalet ^*  (Denmark)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Bacteria; Diet; Gluten; Non obese diabetic (NOD) mice; Type 1 diabetes mellitus

Indexed keywords

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; CECUM; CONTROLLED STUDY; DIABETES MELLITUS; DIGESTION; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; FOOD INTAKE; GLUTEN FREE DIET; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNE RESPONSE; INCIDENCE; INTESTINE FLORA; INTESTINE FUNCTION; LACTOBACILLUS DELBRUECKII; MICROBIOLOGICAL EXAMINATION; MICROCOCCACEAE; MOUSE; MYCOBACTERIUM; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROPHYLAXIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ANIMAL FEED; ANIMALS; CECUM; DIABETES MELLITUS, TYPE 1; DIET; FEMALE; GLUTEN; GRAM-POSITIVE BACTERIA; MICE; MICE, INBRED NOD;

EID: 33744498935     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.609     Document Type: Article

References (47)

1. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999; 15(5): 323-327.
2. Schmid S, Koczwara K, Schwinghammer S, et al. Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. Clin Immunol 2004; 111(1): 108-118.
3. Hoorfar J, Buschard K, Dagnaes-Hansen F. Prophylactic nutritional modification of the incidence of diabetes in autoimmune nonobese diabetic (nod) mice. Br J Nutr 1993; 69(2): 597-607.
4. Flohe SB, Wasmuth HE, Kerad JB, et al. A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. Cytokine 2003; 21(3): 149-154.
5. Secondulfo M, Iafusco D, Carratu R, et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 2004; 36(1): 35-45.
6. Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L. Persistent Mhv (Mouse Hepatitis-Virus) infection reduces the incidence of diabetes-mellitus in nonobese diabetic mice. Diabetologia 1991; 34(1): 2-5.
7. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004; 93(2-3): 97-108.
8. Pozzilli P, Signore A, Williams AJK, Beales PE. Nod mouse colonies around the world - recent facts and figures. Immunol Today 1993; 14(5): 193-196.
9. Bach JF. Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun 2001; 16(3): 347-353.
10. Bras A, Aguas AP. Diabetes-prone NOD mice are resistant to mycobacterium avium and the infection prevents autoimmune disease. Immunology 1996; 89(1): 20-25.
11. Dionisi S, Candeloro P, Grasso F, et al. Oral administration of probiotic compound Vsl#3 prevents the onset of diabetes in NOD mice and is associated to 11-10 up-regulation in gut lymphoid cells. Diabetologia 2002; 45: A152.
12. Gale EAM. A missing link in the hygiene hypothesis? Diabetologia 2002; 45(4): 588-594.
13. Buschard K, Pedersen C, Hansen SV, et al. Anti-diabetogenic effect of fusidic acid in diabetes prone Bb rats. Autoimmunity 1992; 14(2): 101-104.
14. Hageman I, Buschard K. Antidiabetogenic effect of fusidic acid in diabetes prone BB rats: a sex-dependent organ accumulation of the drug is seen. Pharmacol Toxicol 2002; 91(3): 123-128.
15. Nicoletti F, Di Marco R, Conget I, et al. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. J Autoimmun 2000; 15(4): 395-405.
16. Di Cagno R, De Angelis M, Lavermicocca P, et al. Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol 2002; 68(2): 623-633.
17. Gobbetti M, Smacchi E, Fox P, Stepaniak L, Corsetti A. The sourdough microflora, cellular localization and characterization of proteolytic enzymes in lactic acid bacteria. Food Sci Techn Lebensm Wissensch Technol 1996; 29(5-6): 561-569.
18. Cornall RJ, Prins JB, Todd JA, et al. Type-1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome-1. Nature 1991; 353(6341): 262-265.
19. Council of Europe. European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS 123). Council of Europe: Strassbourg, 1986.
20. Public Health Service. PHS Policy on Humane Care and Use of Laboratory Animals. Office of Laboratory Animal Welfare: Bethesda, MD, 2004.
21. Flecknell PA. Laboratory Animal Anaesthesia (2nd edn). Academic Press: London, 1996.
22. Hansen AK. Handbook of Laboratory Animal Bacteriology. CRC Press: Boca Raton, FL, 1999.
23. Scott FW, Sarwar G, Cloutier HE. Diabetogenicity of various protein sources in the diet of BB rats. Adv Exp Med Biol 1988; 246: 277-285.
24. Scott FW, Rowsell P, Wang GS, et al. Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 2002; 51(1): 73-78.
25. Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003; 290(13): 1713-1720.
26. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290(13): 1721-1728.
27. Bach JF. The multifactorial etiology of autoimmune-diseases. Clin Exp Rheumatol 1994; 12: S5-S8.
28. Voot L, Sadewasser S, Kloeting I. The development of BB-Rat diabetes is delayed or prevented by infections or applications of immunogens. Z Versuchstierkd 1988; 31(4): 197.
29. Cummings JH, Beatty ER, Kingman SM, Bingham SA, Englyst HN. Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr 1996; 75(5): 733-747.
30. Venter CS. Effects of dietary propionate on carbohydrate and lipid-metabolism in healthy-volunteers. Am J Gastroenterol 1990; 85(5): 549-553.
31. Brighenti F, Castellani G, Benini L, et al. Effect of neutralized and native vinegar on blood-glucose and acetate responses to a mixed meal in healthy-subjects. Eur J Clin Nutr 1995; 49(4): 242-247.
32. Buschard K. The functional state of the beta cells in the pathogenesis of insulin- dependent diabetes mellitus. Autoimmunity 1991; 10(1): 65-69.
33. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999; 69(5): 1046S-1051S.
34. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2(8): 675-680.
35. Nikulina M, Habich C, Flohe SB, Scott FW, Kolb H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J Immunol 2004; 173(3): 1925-1933.
36. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29(3): 342-346.
37. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357(9262): 1076-1079.
38. Isolauri E, Majamaa H, Arvola T, et al. Lactobacillus-casei strain Gg reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105(6): 1643-1650.
39. Isolauri E, Majamaa H, Arvilommi H. A human lactobacillus strain improves gut mucosal barrier functions. Gastroenterology 1993; 104(4): A716.
40. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002; 8(2): 71-80.
41. Olsson AR, Skogh T, Wingren G. Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann Rheum Dis 2001; 60(10): 934-939.
42. Sudo N, Yu XN, Aiba Y, et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy 2002; 32(7): 1112-1116.
43. Conceicao FR, Zani JL, Gil-Turnes C. Effect of the probiotic CenBiot on the humoral response to an escherichia coli bacterin. Food Agric Immunol 2002; 14(2): 133-138.
44. Matsuzaki T, Nagata Y, Kado S, et al. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of lactobacillus casei. APMIS 1997; 105(8): 643-649.
45. Tabuchi M, Ozaki M, Tamura A, et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003; 67(6): 1421.
46. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292(5519): 1115-1118.
47. Salzman NH, de Jong H, Paterson Y, et al. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology-Sgm 2002; 148: 3651-3660.